Pages that link to "Q38007118"

The following pages link to PI3K/Akt/mTOR and Raf/MEK/ERK signaling pathways perturbations in non-functioning pituitary adenomas (Q38007118):

Displaying 18 items.

• Pituitary Adenoma and the Chemokine Network: A Systemic View (Q26781442) (← links)
• Persistent ERK/MAPK activation promotes lactotrope differentiation and diminishes tumorigenic phenotype (Q34603037) (← links)
• The marine metabolite SZ-685C induces apoptosis in primary human nonfunctioning pituitary adenoma cells by inhibition of the Akt pathway in vitro (Q35228260) (← links)
• Microarray technology reveals potentially novel genes and pathways involved in non-functioning pituitary adenomas (Q37689976) (← links)
• Genome-wide analysis of differentially expressed lncRNAs and mRNAs in primary gonadotrophin adenomas by RNA-seq (Q37706227) (← links)
• Analysis of Ki67, HMGA1, MDM2, and RB expression in nonfunctioning pituitary adenomas (Q37736030) (← links)
• Association of craniopharyngioma and pituitary adenoma (Q38078817) (← links)
• HGF/c-met system targeting PI3K/AKT and STAT3/phosphorylated-STAT3 pathways in pituitary adenomas: an immunohistochemical characterization in view of targeted therapies. (Q38397298) (← links)
• MicroRNA-106b promotes pituitary tumor cell proliferation and invasion through PI3K/AKT signaling pathway by targeting PTEN. (Q38837100) (← links)
• Role of AMP-activated protein kinase activators in antiproliferative multi-drug pituitary tumour therapies: effects of combined treatments with compounds affecting the mTOR-p70S6 kinase axis in cultured pituitary tumour cells. (Q38947158) (← links)
• Morphometric characteristics, cell proliferation parameters and apoptosis indices do not correlate with tendency to relapse in non-functioning pituitary macroadenomas. (Q43537815) (← links)
• Pathogenesis of non-functioning pituitary adenomas (Q48100949) (← links)
• mTOR promotes pituitary tumor development through activation of PTTG1. (Q51571729) (← links)
• The MAPK Pathway-Based Drug Therapeutic Targets in Pituitary Adenomas. (Q64996748) (← links)
• Genome-wide identification of lncRNAs and mRNAs differentially expressed in non-functioning pituitary adenoma and construction of an lncRNA-mRNA co-expression network (Q90027811) (← links)
• Effect of combined treatment with a pan-PI3K inhibitor or an isoform-specific PI3K inhibitor and everolimus on cell proliferation in GH-secreting pituitary tumour in an experimental setting (Q90679554) (← links)
• Lineage-dependent role of miR-410-3p as oncomiR in gonadotroph and corticotroph pituitary adenomas or tumor suppressor miR in somatotroph adenomas via MAPK, PTEN/AKT, and STAT3 signaling pathways (Q92529952) (← links)
• The Treatment of Refractory Pituitary Adenomas (Q92699881) (← links)